Vericel websites use cookies, small text files stored on your browser, to personalize your web experience and to analyze website traffic. By continuing to use this website without changing your settings, you are agreeing to our use of cookies and to our collection of information. For more information about what Vericel collects and how we use it, visit our Privacy Policy.
Aastrom Biosciences to Raise $25.5 Million in Equity Financing Ann Arbor, Michigan, April 6, 2006 – Aastrom Biosciences, Inc. (Nasdaq: ASTM) announced today that it has executed definitive Purchase Agreements for the sale of approximately 15.9 million shares of the Company's common stock in a
Aastrom Biosciences Receives Orphan Drug Designation from the FDA for Proprietary Bone Marrow Cells Ann Arbor, Michigan, March 23, 2006 -- Aastrom Biosciences, Inc. (Nasdaq: ASTM), announced today that the Company's proprietary Tissue Repair Cells (TRCs) received an Orphan Drug Designation from the
Aastrom Biosciences' U.S. Clinical Investigator to Report on Long Bone Fracture Repair Trial Ann Arbor, Michigan, March 22, 2006 -- Aastrom Biosciences, Inc. (Nasdaq: ASTM) announced today that Matthew L. Jimenez, M.D. will present results from his early clinical experience with the first seven
Orthovita and Aastrom Biosciences Announce Collaboration Agreement for Orthopedic Products Ann Arbor, MI and Malvern, PA, March 20, 2006 -- Aastrom Biosciences, Inc. (Nasdaq: ASTM) and Orthovita, Inc. (Nasdaq: VITA) jointly announced today they have signed an agreement to develop products for the
Aastrom Biosciences' Delegates to Present at Two Orthopaedic Meetings Ann Arbor, Michigan, March 16, 2006 -- Aastrom Biosciences, Inc. (Nasdaq: ASTM) announced today that Company representatives are scheduled to speak at the Stem Cell Summit, and at a symposia at the combined meetings of the
Aastrom Biosciences CEO to Present at Cowen & Co. 26th Annual Health Care Conference Ann Arbor, Michigan, March 2, 2006 -- Aastrom Biosciences, Inc. (Nasdaq: ASTM) announced today R. Douglas Armstrong, Ph.D., Chairman and Chief Executive Officer, will present at the Cowen & Co.
Nelson M. Sims Joins Aastrom Biosciences' Board of Directors Ann Arbor, Michigan, February 13, 2006 -- Aastrom Biosciences, Inc. (Nasdaq: ASTM) announced today that Nelson M. Sims has been elected to the Company's Board of Directors. He will serve as a Class III Director whose initial term expires
Aastrom Biosciences, Inc. Reports Second Quarter Fiscal Year 2006 Financial Results Ann Arbor, Michigan, February 8 , 2006 -- Aastrom Biosciences, Inc. (Nasdaq: ASTM) today reported financial results for the second fiscal quarter ended December 31, 2005.
Webcast Alert: Aastrom Biosciences Announces Its Second Quarter Investor Conference Call Ann Arbor, MI, February 6, 2006 -- Aastrom Biosciences (NASDAQ: ASTM ) announces the following Webcast: What: Aastrom Biosciences Second Quarter Fiscal Year End 2006 Investor Conference Call When:
